Literature DB >> 32657915

The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505.

Douglas B Evans.   

Abstract

Entities:  

Year:  2020        PMID： 32657915     DOI： 10.1097/SLA.0000000000004131

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  4 in total

Review 1.  Present status and perspective of perioperative chemotherapy for patients with resectable pancreatic cancer in Japan.

Authors:  Yasuhide Yamada
Journal:  Glob Health Med       Date:  2022-02-28

2.  Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study.

Authors:  Lena Stevens; Zachary J Brown; Ryan Zeh; Christina Monsour; Sharla Wells-Di Gregorio; Heena Santry; Aslam M Ejaz; Timothy Michael Pawlik; Jordan M Cloyd
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

3.  Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma.

Authors:  Zachary J Brown; Hanna E Labiner; Chengli Shen; Aslam Ejaz; Timothy M Pawlik; Jordan M Cloyd
Journal:  J Surg Oncol       Date:  2021-10-02       Impact factor: 2.885

4.  Multi-specialty physician perspectives on barriers and facilitators to the use of neoadjuvant therapy for pancreatic ductal adenocarcinoma.

Authors:  Lena Schreiber; Ryan Zeh; Christina Monsour; Aslam Ejaz; Allan Tsung; Timothy M Pawlik; Eric Miller; Anne Noonan; Somashekar G Krishna; Heena Santry; Jordan M Cloyd
Journal:  HPB (Oxford)       Date:  2021-10-25       Impact factor: 3.842
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.